|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,402.50 GBX | -1.54% |
|
-0.81% | +4.16% |
| 12:33pm | FTSE 100 retreats from record high as tariff worries resurface | RE |
| 12:20pm | European Equities Close Lower in Tuesday Trading; EU Targets Industrial Goods in Tariff Row | MT |
| Capitalization | 57.64B 77.19B 66.48B 61.86B 106B 6,638B 118B 750B 283B 3,105B 290B 284B 11,494B | P/E ratio 2025 * |
10x | P/E ratio 2026 * | 8.89x |
|---|---|---|---|---|---|
| Enterprise value | 70.94B 95.01B 81.82B 76.14B 130B 8,170B 146B 923B 349B 3,822B 356B 349B 14,146B | EV / Sales 2025 * |
2.22x | EV / Sales 2026 * | 2.02x |
| Free-Float |
94.52% | Yield 2025 * |
4.56% | Yield 2026 * | 4.84% |
More valuation ratios
* Estimated data
More news
Last Transcript: GSK plc
| GSK : Receives a Sell rating from JP Morgan | 11:17am | ZD |
| GSK : Deutsche Bank reiterates its Neutral rating | 05:08am | ZD |
| GSK : UBS remains Neutral | Jul. 10 | ZD |
| GSK : UBS reiterates its Neutral rating | Jul. 03 | ZD |
| AlphaValue/Baader Europe Upgrades GSK to Buy, Trims PT | Jul. 01 | MT |
More press releases
More news
| 1 day | -1.23% | ||
| 1 week | -0.81% | ||
| Current month | +0.90% | ||
| 1 month | -5.59% | ||
| 3 months | +4.20% | ||
| 6 months | +5.65% | ||
| Current year | +4.16% |
| 1 week | 1,401.5 |  | 1,495.5 |
| 1 month | 1,380.5 | | 1,507 |
| Current year | 1,242.5 | | 1,560.5 |
| 1 year | 1,242.5 | | 1,678.68 |
| 3 years | 1,242.5 | | 1,823.5 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 56 | 2017-03-31 |
Julie Brown
DFI | Director of Finance/CFO | 63 | 2023-04-30 |
James Ford
CMP | Compliance Officer | - | 2018-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Emma Walmsley
BRD | Director/Board Member | 56 | 2016-12-31 |
Hal Barron
BRD | Director/Board Member | 63 | 2017-12-31 |
Jonathan Symonds
CHM | Chairman | 67 | 2019-08-31 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 3.15% | 21 M€ | +4.65% | - | |
| 2.97% | 57 M€ | +12.46% | - | |
| 2.51% | 7 M€ | +12.99% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.54% | -0.81% | -6.38% | -34.74% | 77.51B | ||
| -2.91% | -0.35% | -18.46% | +133.71% | 718B | ||
| -1.14% | -0.32% | +4.05% | -12.87% | 377B | ||
| -2.38% | -2.23% | +10.42% | +20.78% | 338B | ||
| -2.29% | -3.74% | -55.50% | +3.48% | 308B | ||
| -1.05% | -1.05% | -1.43% | -23.16% | 259B | ||
| -0.38% | -1.69% | -3.07% | +16.27% | 237B | ||
| -1.56% | +1.51% | -13.28% | -5.53% | 222B | ||
| -2.74% | +0.34% | -36.27% | -14.02% | 210B | ||
| -1.23% | -1.26% | -11.18% | +17.92% | 160B | ||
| Average | -1.71% | +1.31% | -13.11% | +10.18% | 290.75B | |
| Weighted average by Cap. | -1.94% | +1.56% | -13.50% | +32.00% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 32B 42.86B 36.91B 34.35B 58.82B 3,686B 65.78B 416B 157B 1,724B 161B 157B 6,382B | 33.75B 45.21B 38.93B 36.23B 62.04B 3,887B 69.38B 439B 166B 1,818B 170B 166B 6,731B |
| Net income | 5.71B 7.65B 6.59B 6.13B 10.49B 658B 11.74B 74.26B 28.08B 308B 28.68B 28.09B 1,139B | 6.43B 8.61B 7.41B 6.9B 11.81B 740B 13.21B 83.6B 31.62B 346B 32.29B 31.63B 1,282B |
| Net Debt | 13.3B 17.82B 15.34B 14.28B 24.45B 1,532B 27.35B 173B 65.43B 717B 66.83B 65.45B 2,653B | 10.64B 14.26B 12.28B 11.42B 19.56B 1,226B 21.88B 138B 52.35B 573B 53.47B 52.36B 2,122B |
More financial data
* Estimated data
Employees
68,629
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-15 | 1,402.50 p | -1.54% | 11,371,670 |
| 25-07-14 | 1,424.50 p | +1.14% | 6,480,863 |
| 25-07-11 | 1,408.50 p | -3.16% | 8,542,394 |
| 25-07-10 | 1,454.50 p | +2.07% | 7,057,049 |
| 25-07-09 | 1,425.00 p | +0.78% | 7,848,611 |
Delayed Quote London S.E., July 15, 2025 at 11:35 am EDT
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
14.24GBP
Average target price
16.30GBP
Spread / Average Target
+14.41%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
